These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26964034)

  • 1. Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study.
    Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Chang KC; Yen YH; Lin MT; Hu TH
    PLoS One; 2016; 11(3):e0149761. PubMed ID: 26964034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with chronic hepatitis B: a prospective cohort study in China.
    Qi X; Wang JY; Mao RC; Zhang JM
    J Viral Hepat; 2015 Jan; 22(1):46-54. PubMed ID: 25402626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis B.
    Qi X; Wang J; Chen L; Huang Y; Qin Y; Mao R; Zhang J
    Medicine (Baltimore); 2015 Apr; 94(15):e646. PubMed ID: 25881837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.
    Lin YS; Shih SC; Wang HY; Lin CC; Chang CW; Chen MJ
    BMC Gastroenterol; 2017 Jan; 17(1):22. PubMed ID: 28137301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Function in Nucleos(t)ide Analog-Treated Patients With Chronic Hepatitis B: A Systematic Literature Review and Network Meta-Analysis.
    Chan HL; Shaikh J; Gupta S; Hamed K
    Adv Ther; 2016 May; 33(5):862-75. PubMed ID: 27146675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
    Kara AV; Yıldırım Y; Ozcicek F; Aldemir MN; Arslan Y; Bayan K; Çelen MK
    Acta Gastroenterol Belg; 2019; 82(2):273-277. PubMed ID: 31314188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telbivudine improves renal function in patients with chronic hepatitis B.
    Gane EJ; Deray G; Liaw YF; Lim SG; Lai CL; Rasenack J; Wang Y; Papatheodoridis G; Di Bisceglie A; Buti M; Samuel D; Uddin A; Bosset S; Trylesinski A
    Gastroenterology; 2014 Jan; 146(1):138-146.e5. PubMed ID: 24067879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patients.
    Wang HM; Hung CH; Lee CM; Lu SN; Wang JH; Yen YH; Kee KM; Chang KC; Tseng PL; Hu TH; Chen CH
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1307-14. PubMed ID: 26758501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
    Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
    Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
    Mallet V; Schwarzinger M; Vallet-Pichard A; Fontaine H; Corouge M; Sogni P; Pol S
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1181-8.e1. PubMed ID: 25460550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy: A Matched Case-Cohort Study.
    Ha NB; Ku K; Ha NB; Chaung KT; Trinh HN; Nguyen MH
    J Clin Gastroenterol; 2015; 49(10):873-7. PubMed ID: 25856383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.
    Pipili C; Cholongitas E; Papatheodoridis G
    Aliment Pharmacol Ther; 2014 Jan; 39(1):35-46. PubMed ID: 24299322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
    Gish RG; Clark MD; Kane SD; Shaw RE; Mangahas MF; Baqai S
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):941-6; quiz e68. PubMed ID: 22507876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.
    Lee M; Oh S; Lee HJ; Yeum TS; Lee JH; Yu SJ; Kim HY; Yoon JH; Lee HS; Kim YJ
    J Viral Hepat; 2014 Dec; 21(12):873-81. PubMed ID: 24351112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of monotherapy with telbivudine or entecavir on renal function in patients with chronic hepatitis B].
    Li W; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):407-11. PubMed ID: 26236924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biomarkers of renal impairment and their application in renal function monitoring during treatment with nucleos(t)ide analogues].
    Li HS; Ma H
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):234-6. PubMed ID: 27095771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B.
    Lee S; Park JY; Song K; Kim DY; Kim BK; Kim SU; Ku HJ; Han KH; Ahn SH
    Gut Liver; 2015 Nov; 9(6):776-83. PubMed ID: 25963085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
    Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
    Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.
    Rodríguez-Nóvoa S; García-Samaniego J; Prieto M; Calleja JL; Pascasio JM; Delgado Blanco M; Crespo J; Buti M; Bonet Vidal ML; Arenas Ruiz Tapiador J; Fernández-Rodríguez C; Solá R; Fraga E; González Diéguez L; Núñez O; Praga M; Del Pino-Montes J; Romero-Gómez M; Morillas R; Diago M; Castro Á;
    J Clin Gastroenterol; 2016 Oct; 50(9):779-89. PubMed ID: 27332746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.